Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells

Janet S. Rasey, John R. Grierson, Linda W. Wiens, Pamella D. Kolb and Jeffrey L. Schwartz
Journal of Nuclear Medicine September 2002, 43 (9) 1210-1217;
Janet S. Rasey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John R. Grierson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda W. Wiens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamella D. Kolb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey L. Schwartz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 9 1210-1217
PubMed 
12215561

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online September 1, 2002.

Copyright & Usage 
THE JOURNAL OF NUCLEAR MEDICINE

Author Information

  1. Janet S. Rasey, PhD1,
  2. John R. Grierson, PhD2,
  3. Linda W. Wiens, BS1,
  4. Pamella D. Kolb, BS1 and
  5. Jeffrey L. Schwartz, PhD1
  1. 1Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington
  2. 2Department of Radiology, University of Washington School of Medicine, Seattle, Washington
View Full Text

Statistics from Altmetric.com

Cited By...

  • 360 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: September 2002 to April 2025

AbstractFullPdf
Sep 20027011193
Oct 200266036
Nov 200274224
Dec 200233015
Jan 200344218
Feb 200322513
Mar 200354418
Apr 200342315
May 200302413
Jun 200352610
Jul 2003133218
Aug 2003111510
Sep 2003203625
Oct 2003163819
Nov 200322259
Dec 2003173724
Jan 2004232825
Feb 2004134027
Mar 2004131713
Apr 2004143517
May 2004154315
Jun 2004245911
Jul 2004375418
Aug 2004216012
Sep 200484315
Oct 200418278
Nov 2004163714
Dec 2004233813
Jan 200519416
Feb 200530267
Mar 2005233514
Apr 200561111
May 200520299
Jun 2005175813
Jul 200514216
Aug 200563111
Sep 200516129
Oct 200561810
Nov 200511168
Dec 200518237
Jan 20061299
Feb 200614910
Mar 200613147
Apr 2006667
May 20061499
Jun 200610135
Jul 2006978
Aug 200652419
Sep 2006131616
Oct 200643323
Nov 200663216
Dec 200643014
Jan 2007121913
Feb 200763421
Mar 2007112115
Apr 200782817
May 200733220
Jun 200771711
Jul 200782719
Aug 200762211
Sep 200792213
Oct 200752511
Nov 200723323
Dec 200731818
Jan 20082911
Feb 200862816
Mar 200842413
Apr 200872420
May 2008142518
Jun 200872519
Jul 200876910
Aug 2008114026
Sep 200892013
Oct 200891913
Nov 2008151510
Dec 200811288
Jan 200932820
Feb 200911156
Mar 2009112327
Apr 200971921
May 20094278
Jun 200972614
Jul 200943212
Aug 200963918
Sep 2009103521
Oct 200962519
Nov 200982016
Dec 2009101111
Jan 201051012
Feb 201082111
Mar 2010212013
Apr 2010202917
May 201082010
Jun 201062217
Jul 20107109
Aug 2010112619
Sep 201014149
Oct 201022158
Nov 2010171919
Dec 2010141814
Jan 2011202914
Feb 2011193612
Mar 2011272516
Apr 2011141613
May 2011191718
Jun 2011392515
Jul 2011371818
Aug 2011261717
Sep 2011342122
Oct 2011462629
Nov 2011352221
Dec 2011302014
Jan 2012432823
Feb 2012311922
Mar 2012322728
Apr 2012524530
May 2012385238
Jun 20123935293
Jul 2012643735
Aug 2012453024
Sep 2012544718
Oct 2012262421
Nov 2012434317
Dec 2012322313
Jan 2013465320
Feb 2013492315
Mar 2013441821
Apr 2013412612
May 2013342417
Jun 2013302017
Jul 2013271423
Aug 20132088
Sep 2013776
Oct 2013161413
Nov 2013141416
Dec 2013151212
Jan 201415919
Feb 2014121418
Mar 2014211311
Apr 2014271926
May 2014221920
Jun 2014181718
Jul 2014161515
Aug 2014865
Sep 2014101417
Oct 2014121016
Nov 2014181214
Dec 20148712
Jan 2015111013
Feb 201515810
Mar 2015642120
Apr 2015201211
May 201515129
Jun 201516514
Jul 2015131312
Aug 201563188
Sep 201542219
Oct 201510811
Nov 201540126
Dec 201543189
Jan 2016571316
Feb 2016341113
Mar 2016221021
Apr 201612516
May 2016172521
Jun 201615239
Jul 2016181118
Aug 2016103912
Sep 2016111512
Oct 2016182317
Nov 201610238
Dec 201612147
Jan 201714197
Feb 201713168
Mar 2017161630
Apr 2017171410
May 2017172410
Jun 201712258
Jul 201711153
Aug 201711164
Sep 2017141113
Oct 2017241712
Nov 2017936
Dec 20177147
Jan 20181398
Feb 2018101613
Mar 2018151311
Apr 2018484
May 201812166
Jun 20180141
Jul 2018486
Aug 2018264
Sep 2018467
Oct 201891218
Nov 2018251113
Dec 2018359
Jan 201981318
Feb 201952118
Mar 201972120
Apr 2019112021
May 20196111
Jun 20198124
Jul 2019121219
Aug 2019988
Sep 201911510
Oct 2019528
Nov 20191163
Dec 2019855
Jan 2020705
Feb 2020608
Mar 202015211
Apr 20204413
May 20202035
Jun 20209810
Jul 2020455
Aug 20201536
Sep 202011529
Oct 20201436
Nov 20209511
Dec 20209714
Jan 20219730
Feb 2021192316
Mar 202110118
Apr 20211177
May 202115136
Jun 20211599
Jul 20219157
Aug 20211176
Sep 20217132
Oct 202112135
Nov 202181215
Dec 20218119
Jan 2022181913
Feb 202210815
Mar 20221389
Apr 202214158
May 202213147
Jun 2022586
Jul 202234414
Aug 202212129
Sep 202210244
Oct 20228225
Nov 20221168
Dec 202212167
Jan 202321194
Feb 20238201
Mar 202393210
Apr 202314130
May 2023786
Jun 20238298
Jul 2023141822
Aug 2023131414
Sep 20235103
Oct 20233124
Nov 20235269
Dec 20235622
Jan 20245389
Feb 2024183710
Mar 20244215
Apr 2024313512
May 20243925
Jun 20247488
Jul 202485811
Aug 2024129111
Sep 2024125710
Oct 2024785
Nov 202414143
Dec 202434410
Jan 20250646
Feb 2025151127
Mar 202561019
Apr 2025614821
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 43, Issue 9
September 1, 2002
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells
Janet S. Rasey, John R. Grierson, Linda W. Wiens, Pamella D. Kolb, Jeffrey L. Schwartz
Journal of Nuclear Medicine Sep 2002, 43 (9) 1210-1217;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells
Janet S. Rasey, John R. Grierson, Linda W. Wiens, Pamella D. Kolb, Jeffrey L. Schwartz
Journal of Nuclear Medicine Sep 2002, 43 (9) 1210-1217;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
  • Streptococcus pneumoniae Binds to Host Lactate Dehydrogenase via PspA and PspC To Enhance Virulence
  • 17-Allylamino-17-demethoxygeldanamycin-induced Changes in [18F]Fluorothymidine Uptake
  • Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients
  • Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy
  • Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model
  • The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis
  • Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging
  • 18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
  • PET Imaging During Radiotherapy of Head and Neck Cancer
  • 3'-Deoxy-3'-18F-Fluorothymidine PET Predicts Response to V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer
  • Correlation of 18F-FLT Uptake with Tumor Grade and Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas
  • Usefulness of 3'-Deoxy-3'-18F-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer
  • [18F]FLT-PET Imaging Does Not Always "Light Up" Proliferating Tumor Cells
  • PET Imaging of Tumor Growth: Not as Easy as It Looks
  • 4'-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non-Small Cell Lung Cancer
  • Pharmacodynamic Study Using FLT PET/CT in Patients with Renal Cell Cancer and Other Solid Malignancies Treated with Sunitinib Malate
  • Multimodality Assessment of Brain Tumors and Tumor Recurrence
  • Tumor 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors
  • Quantitative Analysis of Thymidine Kinase 1 and 5'(3')-Deoxyribonucleotidase mRNA Expression: The Role of Fluorothymidine Uptake
  • The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture
  • Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
  • 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
  • PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?
  • Noninvasive Imaging of Endogenous Neural Stem Cell Mobilization In Vivo Using Positron Emission Tomography
  • Histopathologic Validation of 3'-Deoxy-3'-18F-Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity
  • Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy
  • PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
  • Cytotoxicity of {sigma}-Receptor Ligands Is Associated with Major Changes of Cellular Metabolism and Complete Occupancy of the {sigma}-2 Subpopulation
  • First Demonstration of Leukemia Imaging with the Proliferation Marker 18F-Fluorodeoxythymidine
  • The Role of Human Nucleoside Transporters in Uptake of 3'-Deoxy-3'-fluorothymidine
  • Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901
  • Glioma Proliferation as Assessed by 3'-Fluoro-3'-Deoxy-L-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma
  • 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition
  • Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study
  • Clinical Applications of PET in Brain Tumors
  • Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma
  • Multimodality Molecular Imaging of Glioblastoma Growth Inhibition with Vasculature-Targeting Fusion Toxin VEGF121/rGel
  • Molecular Imaging of Proliferation in Malignant Lymphoma.
  • Early Response of {sigma}-Receptor Ligands and Metabolic PET Tracers to 3 Forms of Chemotherapy: An In Vitro Study in Glioma Cells
  • Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3'-Deoxy-3'-3H-Fluorothymidine Using Preclinical Tumor Models
  • In vivo Biological Activity of the Histone Deacetylase Inhibitor LAQ824 Is detectable with 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography
  • 18F-Fluoro-L-Thymidine and 11C-Methylmethionine as Markers of Increased Transport and Proliferation in Brain Tumors
  • Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging: Evaluation of Analytical Methods
  • Reproducibility of 3'-Deoxy-3'-18F-Fluorothymidine MicroPET Studies in Tumor Xenografts in Mice
  • Imaging Proliferation in Brain Tumors with 18F-FLT PET: Comparison with 18F-FDG
  • Early Detection of Tumor Response to Chemotherapy by 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor Model In vivo
  • Kinetic Analysis of 3'-Deoxy-3'-Fluorothymidine PET Studies: Validation Studies in Patients with Lung Cancer
  • Kinetic Modeling of 3'-Deoxy-3'-Fluorothymidine in Somatic Tumors: Mathematical Studies
  • Monitoring Antiproliferative Responses to Kinase Inhibitor Therapy in Mice with 3'-Deoxy-3'-18F-Fluorothymidine PET
  • Selectivity of 18F-FLT and 18F-FDG for Differentiating Tumor from Inflammation in a Rodent Model
  • Monitoring of Therapy in Androgen-Dependent Prostate Tumor Model by Measuring Tumor Proliferation
  • Oncological molecular imaging: nuclear medicine techniques
  • Reply
  • Monitoring Tumor Cell Proliferation by Targeting DNA Synthetic Processes with Thymidine and Thymidine Analogs
  • Molecular Targeting with Radionuclides: State of the Science
  • In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
  • PET Imaging with 18F-FLT and Thymidine Analogs: Promise and Pitfalls
  • Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG
  • 18F-Fluorothymidine Radiation Dosimetry in Human PET Imaging Studies
  • 3'-Deoxy-3'-[18F]Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography
  • 3'-[18F]Fluoro-3'-Deoxythymidine ([18F]-FLT) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease
  • Google Scholar

More in this TOC Section

  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire